J&J begins phase 3 trial of Covid-19 vaccine candidate JNJ-78436735

This article was originally published here

The late-stage trial called ENSEMBLE to be held in multiple countries across three countries will study the safety and efficacy of a single dosage of JNJ-78436735 in comparison

The post J&J begins phase 3 trial of Covid-19 vaccine candidate JNJ-78436735 appeared first on Pharmaceutical Business review.